A Phase 3B, Randomized, Double-Blind Clinical Trial to Evaluate the Efficacy and Safety of Abatacept SC in Combination With Methotrexate Compared to Methotrexate Monotherapy in Achieving Clinical Remission in Adults With Early Rheumatoid Arthritis Who Are Methotrexate Naive
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 31 Jan 2018
At a glance
- Drugs Abatacept (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Acronyms AVERT-2
- Sponsors Bristol-Myers Squibb
- 29 Nov 2017 Planned End Date changed from 1 Feb 2020 to 20 Mar 2020.
- 10 Jun 2017 Biomarkers information updated
- 23 Apr 2017 This trial has been completed in Finland.